Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors

Hisashi Masuyama, Etsuko Nobumoto, Tomonori Segawa, Yuji Hiramatsu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Preeclampsia may be due to an excess of circulating anti-angiogenic growth factors derived from the placenta, but metabolic syndrome-like disorders may also set off a cascade of placental and systemic inflammation and oxidative stress. We present a case of severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors, in which diet therapy ameliorated the preeclamptic signs while improving the adiponectin level. A 41-year-old pregnant woman with obesity and diabetes was referred to our hospital because of severe proteinuria and hypertension at 22 weeks of gestation. After administration of insulin and hydralazine with diet therapy, her hypertension and proteinuria were ameliorated with a 15-kg weight loss. Her adiponectin level was low and her leptin level was high, but her angiogenic factor levels were within the normal ranges for pregnant women at admission. The diet therapy ameliorated her hypertension and proteinuria while improving her adiponectin level as she achieved weight loss. This case suggests that diet therapy for obese preeclampsia patients with a mild imbalance of anti-and pro-angiogenic factors may play an important role in managing preeclampsia. Measurements of maternal adipocytokines and angiogenic factors may be important to distinguish the main cause of preeclampsia, i.e., poor placentation or maternal constitutional factors, for managing preeclampsia in patients with obesity.

Original languageEnglish
Pages (from-to)171-176
Number of pages6
JournalActa Medica Okayama
Volume66
Issue number2
Publication statusPublished - 2012

Fingerprint

Angiogenesis Inducing Agents
Nutrition
Medical problems
Pre-Eclampsia
Diet Therapy
Adiponectin
Obesity
Proteinuria
Hypertension
Hydralazine
Adipokines
Oxidative stress
Weight Loss
Pregnant Women
Leptin
Mothers
Placentation
Intercellular Signaling Peptides and Proteins
Insulin
Placenta

Keywords

  • adipocytokine
  • Angiogenic factor
  • Diettherapy
  • Obesity
  • Preeclampsia

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. / Masuyama, Hisashi; Nobumoto, Etsuko; Segawa, Tomonori; Hiramatsu, Yuji.

In: Acta Medica Okayama, Vol. 66, No. 2, 2012, p. 171-176.

Research output: Contribution to journalArticle

Masuyama, Hisashi ; Nobumoto, Etsuko ; Segawa, Tomonori ; Hiramatsu, Yuji. / Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. In: Acta Medica Okayama. 2012 ; Vol. 66, No. 2. pp. 171-176.
@article{c132592530e24bfa891da4cefbe05903,
title = "Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors",
abstract = "Preeclampsia may be due to an excess of circulating anti-angiogenic growth factors derived from the placenta, but metabolic syndrome-like disorders may also set off a cascade of placental and systemic inflammation and oxidative stress. We present a case of severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors, in which diet therapy ameliorated the preeclamptic signs while improving the adiponectin level. A 41-year-old pregnant woman with obesity and diabetes was referred to our hospital because of severe proteinuria and hypertension at 22 weeks of gestation. After administration of insulin and hydralazine with diet therapy, her hypertension and proteinuria were ameliorated with a 15-kg weight loss. Her adiponectin level was low and her leptin level was high, but her angiogenic factor levels were within the normal ranges for pregnant women at admission. The diet therapy ameliorated her hypertension and proteinuria while improving her adiponectin level as she achieved weight loss. This case suggests that diet therapy for obese preeclampsia patients with a mild imbalance of anti-and pro-angiogenic factors may play an important role in managing preeclampsia. Measurements of maternal adipocytokines and angiogenic factors may be important to distinguish the main cause of preeclampsia, i.e., poor placentation or maternal constitutional factors, for managing preeclampsia in patients with obesity.",
keywords = "adipocytokine, Angiogenic factor, Diettherapy, Obesity, Preeclampsia",
author = "Hisashi Masuyama and Etsuko Nobumoto and Tomonori Segawa and Yuji Hiramatsu",
year = "2012",
language = "English",
volume = "66",
pages = "171--176",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "2",

}

TY - JOUR

T1 - Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors

AU - Masuyama, Hisashi

AU - Nobumoto, Etsuko

AU - Segawa, Tomonori

AU - Hiramatsu, Yuji

PY - 2012

Y1 - 2012

N2 - Preeclampsia may be due to an excess of circulating anti-angiogenic growth factors derived from the placenta, but metabolic syndrome-like disorders may also set off a cascade of placental and systemic inflammation and oxidative stress. We present a case of severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors, in which diet therapy ameliorated the preeclamptic signs while improving the adiponectin level. A 41-year-old pregnant woman with obesity and diabetes was referred to our hospital because of severe proteinuria and hypertension at 22 weeks of gestation. After administration of insulin and hydralazine with diet therapy, her hypertension and proteinuria were ameliorated with a 15-kg weight loss. Her adiponectin level was low and her leptin level was high, but her angiogenic factor levels were within the normal ranges for pregnant women at admission. The diet therapy ameliorated her hypertension and proteinuria while improving her adiponectin level as she achieved weight loss. This case suggests that diet therapy for obese preeclampsia patients with a mild imbalance of anti-and pro-angiogenic factors may play an important role in managing preeclampsia. Measurements of maternal adipocytokines and angiogenic factors may be important to distinguish the main cause of preeclampsia, i.e., poor placentation or maternal constitutional factors, for managing preeclampsia in patients with obesity.

AB - Preeclampsia may be due to an excess of circulating anti-angiogenic growth factors derived from the placenta, but metabolic syndrome-like disorders may also set off a cascade of placental and systemic inflammation and oxidative stress. We present a case of severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors, in which diet therapy ameliorated the preeclamptic signs while improving the adiponectin level. A 41-year-old pregnant woman with obesity and diabetes was referred to our hospital because of severe proteinuria and hypertension at 22 weeks of gestation. After administration of insulin and hydralazine with diet therapy, her hypertension and proteinuria were ameliorated with a 15-kg weight loss. Her adiponectin level was low and her leptin level was high, but her angiogenic factor levels were within the normal ranges for pregnant women at admission. The diet therapy ameliorated her hypertension and proteinuria while improving her adiponectin level as she achieved weight loss. This case suggests that diet therapy for obese preeclampsia patients with a mild imbalance of anti-and pro-angiogenic factors may play an important role in managing preeclampsia. Measurements of maternal adipocytokines and angiogenic factors may be important to distinguish the main cause of preeclampsia, i.e., poor placentation or maternal constitutional factors, for managing preeclampsia in patients with obesity.

KW - adipocytokine

KW - Angiogenic factor

KW - Diettherapy

KW - Obesity

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=84864744737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864744737&partnerID=8YFLogxK

M3 - Article

C2 - 22525475

AN - SCOPUS:84864744737

VL - 66

SP - 171

EP - 176

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 2

ER -